The tool aims to speed up medical imaging research and AI model development across healthcare and is integrated with NVIDIA MONAI, part of the NVIDIA AI Enterprise software platform.

The platform facilitates a process to prepare and train data for AI model development and supports research among pharmaceutical and life sciences companies, research institutions and healthcare providers.

The Flywheel collaboration with Microsoft and NVIDIA aims to help researchers and healthcare professionals manage, curate and analyse medical imaging data to extract and mobilise insights that support personalised care, clinical research and real-world evidence.

Trent Norris, chief revenue officer at Flywheel, said: “The synergy between Microsoft Azure Machine Learning, NVIDIA MONAI and Microsoft’s advanced services creates a robust platform that is integral to our mission.

“This unified approach is not just about technology. It’s about empowering researchers, clinicians, and scientists around the world with the proven scalability of our AI enabling solutions. It enables them to accelerate discovery, drive innovation and, ultimately, enhance healthcare outcomes globally.”

Peter Durlach, corporate vice-president, health and life sciences at Microsoft, added: “Flywheel’s expertise in medical imaging, combined with the power and scale of Azure, along with the advanced imaging analytics capabilities of mPower, is ushering in a new era of healthcare innovation.

“Our partnership is geared towards a future where Flywheel’s platform combined with Microsoft’s cloud and AI capabilities will help transform patient care through accelerated discovery and AI-driven insights.”